Company Encyclopedia
View More
name
EUROEYES
01846.HK
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, the People’s Republic of China, Denmark, and the United Kingdom. The company offers laser eye surgery in various options, including SMILE Pro, Femto-Lasik, PRK, and Lasek; refractive laser surgery, such as ReLEx SMILE, Femto LASIK, and Presbyond; lens exchange surgery comprising monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. It also sells pharmaceutical products; rental of ophthalmic equipment and operating spaces; and provides training service. In addition, the company is involved in the operation of consultation centers and/or clinics for eye treatment, as well as LASIK centers; and trading of eye clinic equipment and lenses.
52.63 B
01846.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking9/28
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.35%C
    • Profit Margin10.56%B
    • Gross Margin41.58%B
  • Growth ScoreC
    • Revenue YoY-1.61%D
    • Net Profit YoY-29.08%D
    • Total Assets YoY5.90%B
    • Net Assets YoY10.37%B
  • Cash ScoreC
    • Cash Flow Margin946.55%B
    • OCF YoY-1.61%D
  • Operating ScoreC
    • Turnover0.41C
  • Debt ScoreB
    • Gearing Ratio28.29%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    EuroEyes International Eye Clinic's Eyes Surgeries Jump 5.6% in Q3

    EuroEyes International Eye Clinic's Eyes Surgeries Jump 5.6% in Q3

    marketscreener·
    HK
    01846
    +1.91%
    marketscreener·
    HK
    01846
    +1.91%

    EuroEyes Reports 5.6% Increase in Eye Surgeries for Third Quarter 2025

    EuroEyes International Eye Clinic Limited reported a 5.6% increase in eye surgeries for Q3 2025, totaling 6,807 surgeries. The growth is attributed to higher demand for lens exchange and laser surgeries. The figures are unaudited and may differ from final results. Shareholders are advised to exercise caution with company shares. The original content was published on November 14, 2025.

    Reuters·
    HK
    01846
    +1.91%
    Reuters·
    HK
    01846
    +1.91%

    Euroeyes International Eye Clinic Says Euroeyes Swiss To Buy Assets For CHF12 Million

    Euroeyes International Eye Clinic Ltd :EUROEYES SWISS TO BUY ASSETS FOR CHF12 MILLIONASSETS INCLUDE 7 MEDICAL CLINICS FOR REFRACTIVE SURGERY, OTHERS

    Reuters·
    HK
    01846
    +1.91%
    Reuters·
    HK
    01846
    +1.91%

    EuroEyes Expands European Operations with Strategic Acquisitions

    EuroEyes International Eye Clinic Limited (HK:1846) has announced strategic acquisitions in Switzerland and the UK, acquiring medical clinics and assets for refractive surgery valued at CHF12,010,000 and CHF200,000, respectively. These transactions are discloseable under Hong Kong Stock Exchange Listing Rules, marking a significant expansion in EuroEyes' operational capacity in Europe. The latest analyst rating for HK:1846 is a Hold with a price target of HK$3.50. EuroEyes specializes in eye care and corrective surgeries, with a current market cap of HK$943.3M.

    Tip Ranks·
    HK
    01846
    +1.91%
    Tip Ranks·
    HK
    01846
    +1.91%

    EUROEYES plans to spend approximately HKD 119 million to acquire ophthalmic assets in Switzerland and the UK, strengthening its presence in the European refractive surgery market

    EUROEYES announced plans to acquire ophthalmic assets in Switzerland and the UK for approximately HKD 117 million and HKD 1.94886 million, respectively, through its wholly-owned subsidiaries EuroEyes Swiss and EuroEyes UK. This acquisition will enhance its presence in the European refractive surgery market, with the Swiss assets including seven refractive surgery medical clinics and related equipment and intellectual property

    Zhitong·
    HK
    01846
    +1.91%
    Zhitong·
    HK
    01846
    +1.91%
    © 2025 Longbridge｜Disclaimer